Baton Rouge, Louisiana
7 Day Forecast

Latest Weather Blog

Follow our weather team on social media

Drug shows promise for people with mild Alzheimer's

2 years ago October 08, 2012 Oct 8, 2012 Monday, October 08 2012 Monday, October 08, 2012 6:33:34 PM CDT in News
Source: Associated Press
By: Michael Marsh

Two studies to test an experimental drug to treat mild cases of Alzheimer's seem to show that doctors are on the right track by trying to clear the sticky deposits that clog's patient's brains. The combined results from testing of the drug suggest it might modestly slow mental decline. Taken separately, the studies missed their main goal to significantly slow the mind-robbing disease. But pooled results show 34 percent less delcine in mild Alzheimer's patients compared to those on a placebo for 18 months. The drug is called solanezumab and is developed by Eli Lilly & Company.

More News

comments powered by Disqus

Desktop News

Click to open Continuous News in a sidebar that updates in real-time.
7 Days